Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma

被引：0
|
作者：
Jonas Ecker
Ina Oehme
Ralph Mazitschek
Andrey Korshunov
Marcel Kool
Thomas Hielscher
Judit Kiss
Florian Selt
Carina Konrad
Marco Lodrini
Hedwig E Deubzer
Andreas von Deimling
Andreas E Kulozik
Stefan M Pfister
Olaf Witt
Till Milde
机构：
[1] German Cancer Research Center (DKFZ),Clinical Cooperation Unit Pediatric Oncology (G340)
[2] Massachusetts General Hospital,Center for Systems Biology
[3] The Broad Institute of Harvard and MIT,Department of Neuropathology
[4] University Hospital Heidelberg,Clinical Cooperation Unit Neuropathology (G380)
[5] German Cancer Research Center (DKFZ),Division of Pediatric Neurooncology (B062)
[6] and German Cancer Consortium (DKTK),Division of Biostatistics (C060)
[7] German Cancer Research Center (DKFZ),Section of Pediatric Brain Tumors, Department of Pediatric Oncology, Hematology and Immunology
[8] Heidelberg,Department of Pediatric Hematology
[9] Germany,undefined
[10] and German Cancer Consortium (DKTK),undefined
[11] German Cancer Consortium (DKTK),undefined
[12] German Cancer Research Center (DKFZ),undefined
[13] University Hospital Heidelberg,undefined
[14] Oncology and Bone Marrow Transplantation,undefined
[15] Charité - University Medicine Berlin,undefined
来源：
Acta Neuropathologica Communications | / 3卷
关键词：
Medulloblastoma; HDAC; HDAC inhibitor; HDAC2; MYC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Restoration of miR-193a expression is tumor-suppressive in MYC amplified Group 3 medulloblastoma
    Bharambe, Harish Shrikrishna
    Joshi, Annada
    Yogi, Kedar
    Kazi, Sadaf
    Shirsat, Neelam Vishwanath
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2020, 8 (01)
  • [22] Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells
    Gintvile Valinciute
    Jonas Ecker
    Florian Selt
    Thomas Hielscher
    Romain Sigaud
    Johannes Ridinger
    Venu Thatikonda
    Charlotte Gatzweiler
    Sarah Robinson
    Julie Talbot
    Flavia Bernardi
    Daniel Picard
    Mirjam Blattner-Johnson
    Simone Schmid
    David T. Jones
    Cornelis M. van Tilburg
    David Capper
    Marcel Kool
    Marc Remke
    Ina Oehme
    Stefan M. Pfister
    Martine F. Roussel
    Olivier Ayrault
    Olaf Witt
    Till Milde
    Journal of Neuro-Oncology, 2023, 163 : 143 - 158
  • [23] Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells
    Valinciute, Gintvile
    Ecker, Jonas
    Selt, Florian
    Hielscher, Thomas
    Sigaud, Romain
    Ridinger, Johannes
    Thatikonda, Venu
    Gatzweiler, Charlotte
    Robinson, Sarah
    Talbot, Julie
    Bernardi, Flavia
    Picard, Daniel
    Blattner-Johnson, Mirjam
    Schmid, Simone
    Jones, David T.
    van Tilburg, Cornelis M.
    Capper, David
    Kool, Marcel
    Remke, Marc
    Oehme, Ina
    Pfister, Stefan M.
    Roussel, Martine F.
    Ayrault, Olivier
    Witt, Olaf
    Milde, Till
    JOURNAL OF NEURO-ONCOLOGY, 2023, 163 (01) : 143 - 158
  • [24] TARGETING PBK IN GROUP 3 MEDULLOBLASTOMA
    Shahab, Shubin W.
    Kenney, Anna M.
    Macdonald, Tobey J.
    NEURO-ONCOLOGY, 2024, 26
  • [25] TARGETING CLASS I HISTONE DEACETYLASES IN HIGH RISK MEDULLOBLASTOMA - ANALYSIS OF MOLECULAR MECHANISMS AND TRANSLATIONAL IMPLICATIONS
    Ecker, Jonas
    Oehme, Ina
    Mazitschek, Ralph
    Korshunov, Andrey
    Kool, Marcel
    Lodrini, Marco
    Deubzer, Hedwig E.
    von Deimling, Andreas
    Kulozik, Andreas E.
    Pfister, Stefan M.
    Witt, Olaf
    Milde, Till
    NEURO-ONCOLOGY, 2014, 16 : 80 - 80
  • [26] TARGETING CLASS I HISTONE DEACETYLASE IN RENAL TUBULAR EPITHELIAL CELLS INHIBITS PRIMING INFLAMMATORY RESPONSES
    Kang, Sunwoo
    Kim, Yeonghoon
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 595 - 595
  • [27] The histone deacetylase SIRT2 stabilizes Myc oncoproteins
    Liu, P. Y.
    Xu, N.
    Malyukova, A.
    Scarlett, C. J.
    Sun, Y. T.
    Zhang, X. D.
    Ling, D.
    Su, S-P
    Nelson, C.
    Chang, D. K.
    Koach, J.
    Tee, A. E.
    Haber, M.
    Norris, M. D.
    Toon, C.
    Rooman, I.
    Xue, C.
    Cheung, B. B.
    Kumar, S.
    Marshall, G. M.
    Biankin, A. V.
    Liu, T.
    CELL DEATH AND DIFFERENTIATION, 2013, 20 (03): : 503 - 514
  • [28] The histone deacetylase SIRT2 stabilizes Myc oncoproteins
    P Y Liu
    N Xu
    A Malyukova
    C J Scarlett
    Y T Sun
    X D Zhang
    D Ling
    S-P Su
    C Nelson
    D K Chang
    J Koach
    A E Tee
    M Haber
    M D Norris
    C Toon
    I Rooman
    C Xue
    B B Cheung
    S Kumar
    G M Marshall
    A V Biankin
    T Liu
    Cell Death & Differentiation, 2013, 20 : 503 - 514
  • [29] OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma
    Xu, Zhenhua
    Murad, Najiba
    Malawsky, Daniel
    Tao, Ran
    Rivero-Hinojosa, Samuel
    Holdhof, Doerthe
    Schueller, Ulrich
    Zhang, Peng
    Lazarski, Christopher
    Rood, Brian R.
    Packer, Roger
    Gershon, Timothy
    Pei, Yanxin
    CLINICAL CANCER RESEARCH, 2022, 28 (19) : 4278 - 4291
  • [30] MYC DRIVEN IMMUNE SUPPRESSION IN GROUP 3 MEDULLOBLASTOMA
    Mitra, Siddhartha
    Picard, Daniel
    Qin, Nan
    Cole, Allison
    Cruz, Joselyn Cruz
    Marquardt, Viktoria
    Venkataraman, Sujatha
    Vibhakar, Rajeev
    Remke, Marc
    NEURO-ONCOLOGY, 2022, 24 : 139 - 139
12345